Investor Notice: Feb 28th Deadline for certain Investors in Instadose Pharma Corp. shares announced by Shareholders Foundation
SAN DIEGO, Feb. 16, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a deadline is coming up on February 28, 2022, in the lawsuit that was filed for certain investors in OTC: INSD shares.
Investors who have losses of over
On December 30, 2021, a lawsuit was filed against Instadose Pharma Corp. The plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that Instadose had performed inadequate due diligence into the Business Combination and/or ignored significant red flags associated with Instadose Canada, that Instadose's internal controls and policies were inadequate to detect and/or prevent impermissible trading activity by control persons of the Company, that the foregoing subjected Instadose to a heightened risk of regulatory scrutiny and enforcement action, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Instadose Pharma Corp. (OTC: INSD) should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-notice-feb-28th-deadline-for-certain-investors-in-instadose-pharma-corp-shares-announced-by-shareholders-foundation-301483383.html
SOURCE Shareholders Foundation, Inc.
